Biodesix raised $22 million through the sale of series F preferred stock and other securities.
In addition to the $15 million of series shares in 2013 and 2014, Biodesix brought in another $12 million, for total proceeds of $27 million from the sale.
Biodesix Inc. announced today that the company has raised $7.1 million in new equity financing, led by existing investors.